Evaluation of the Effect of Para-sternal Block on Postoperative Respiratory Function After Cardiac Sternotomy Surgery
NCT ID: NCT05515809
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
84 participants
INTERVENTIONAL
2022-07-19
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)
NCT05345639
Intraoperative Paravertebral Block and Postoperative Complications
NCT07211529
Ultrasound-Guided Serratus Anterior Plane Block for Additional Pain Relief After Lung Surgery
NCT04238455
Stellate Ganglion Block
NCT06271707
Evaluation of Patient Analgesia After Bloc Serratus
NCT04123977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
interventional arm
the experimental arm will receive the parasternal block with injection of locoregional anesthesia
parasternal block
Echo-guided loco-regional anesthesia by bilateral parasternal block in immediate preoperative.
The drug used is Ropivacaine 2mg/ml, 0.2%. Injection of 20ml per side, under ultrasound control, after general anaesthesia and before skin incision, and therefore before surgery
control arm not requiring loco-regional anesthesia.
the control arm will receive a standard treatment, without locoregional anesthesia
Standard pain management
Standard pain management care involves a multimodal strategy that includes the use of intravenous analgesics. Morphine medications are the mainstay of pain management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
parasternal block
Echo-guided loco-regional anesthesia by bilateral parasternal block in immediate preoperative.
The drug used is Ropivacaine 2mg/ml, 0.2%. Injection of 20ml per side, under ultrasound control, after general anaesthesia and before skin incision, and therefore before surgery
Standard pain management
Standard pain management care involves a multimodal strategy that includes the use of intravenous analgesics. Morphine medications are the mainstay of pain management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective cardiac surgery under CEC with sternotomy
* Written informed consent from the patient.
* Women of childbearing age must have a negative urine HCG pregnancy test.
Exclusion Criteria
* Mini-sternotomy approach
* Opioid drug dependence or chronic opioid drug use
* Chronic benzodiazepine use (respiratory depressant treatment or treatment that may affect postoperative respiratory function)
* Contraindication or allergy to local anesthetics
* Emergency surgery
* Acute infective endocarditis
* Immunosuppressive or steroid treatment (prednisone \> 0.5mg/kg/day or equivalent)
* AIDS with CD4 count \<200/mm3
* Autoimmune disorder
* Transplant recipient
* Inclusion in another study within the last 30 days.
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens-Picardie
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2021_843_0229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.